Accumulating evidence suggests that IL-6 may contribute to the maintenance of normal systemic glucose metabolism and that the increased circulating IL-6 concentrations during obesity may actually be an adaptive mechanism to resist obesity-associated glucose intolerance [92,93]. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.